EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document C:2016:023:TOC
Official Journal of the European Union, C 23, 22 January 2016
Official Journal of the European Union, C 23, 22 January 2016
Official Journal of the European Union, C 23, 22 January 2016
ISSN 1977-091X |
||
Official Journal of the European Union |
C 23 |
|
![]() |
||
English edition |
Information and Notices |
Volume 59 |
Notice No |
Contents |
page |
|
II Information |
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2016/C 23/01 |
Non-opposition to a notified concentration (Case M.7671 — KKR/FIBA/WMF) ( 1 ) |
1 |
2016/C 23/02 |
Non-opposition to a notified concentration (Case M.7855 — Ageas/AXA Portugal) ( 1 ) |
1 |
2016/C 23/03 |
Non-opposition to a notified concentration (Case M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)) ( 1 ) |
2 |
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2016/C 23/04 |
3 |
|
2016/C 23/05 |
4 |
|
2016/C 23/06 |
5 |
|
V Announcements |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
European Commission |
|
2016/C 23/07 |
Prior notification of a concentration (Case M.7869 — Macquarie/Dolomiti Energia/Hydro Dolomiti Enel) — Candidate case for simplified procedure ( 1 ) |
6 |
|
|
|
(1) Text with EEA relevance |
EN |
|